HKSE:00954 (China)
Â
Class H
HK$
0.22
(0%)
Sep 9
Business Description
Changmao Biochemical Engineering Co Ltd
ISIN : CNE100000106
Share Class Description:
HKSE:00954: Class HTotal Employee Number:
518Compare
Compare
Traded in other countries / regions
00954.Hong Kong IPO Date
2002-06-28Description
Changmao Biochemical Engineering Co Ltd is an organic acid producer in the PRC. It produces organic acids products for sale to the food additive, chemical, and pharmaceutical industries. Its products are organic acids and their derivatives with four carbons in their structures including fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, L(+)-tartaric acid, D(-)-tartaric acid, DL-tartaric acid, L-aspartic acid, and aspartame. These products are used as food additives or medical intermediaries. Its products are produced along vertical production chains. Its geographic locations include Mainland China, Europe includes Great Britain, Germany, Turkey, Spain, and Italy, Asia Pacific includes Hong Kong, Indonesia, Australia, India, Thailand and Japan, America, and Others.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.08 | |||||
Equity-to-Asset | 0.45 | |||||
Debt-to-Equity | 0.96 | |||||
Debt-to-EBITDA | -23.33 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 0.48 | |||||
Beneish M-Score | -2.74 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -8.9 | |||||
3-Year EBITDA Growth Rate | -63.1 | |||||
3-Year Book Growth Rate | -13.1 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 7.34 | |||||
9-Day RSI | 8.87 | |||||
14-Day RSI | 10.05 | |||||
3-1 Month Momentum % | -23.08 | |||||
6-1 Month Momentum % | -24.24 | |||||
12-1 Month Momentum % | -21.88 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.44 | |||||
Quick Ratio | 0.22 | |||||
Cash Ratio | 0.08 | |||||
Days Inventory | 83.01 | |||||
Days Sales Outstanding | 31.32 | |||||
Days Payable | 24.73 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -1.22 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 8.37 | |||||
Operating Margin % | -4.01 | |||||
Net Margin % | -7.85 | |||||
EBITDA Margin % | -3.73 | |||||
FCF Margin % | 1.82 | |||||
OCF Margin % | 8.37 | |||||
ROE % | -8.63 | |||||
ROA % | -3.86 | |||||
ROIC % | -1.64 | |||||
3-Year ROIIC % | -37.53 | |||||
ROC (Joel Greenblatt) % | -2.27 | |||||
ROCE % | -3.43 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shiller PE Ratio | 10.9 | |||||
PS Ratio | 0.17 | |||||
PB Ratio | 0.19 | |||||
Price-to-Tangible-Book | 0.19 | |||||
Price-to-Free-Cash-Flow | 9.92 | |||||
Price-to-Operating-Cash-Flow | 2.11 | |||||
EV-to-EBIT | -26.54 | |||||
EV-to-EBITDA | -26.54 | |||||
EV-to-Revenue | 0.99 | |||||
EV-to-FCF | 54.44 | |||||
Price-to-GF-Value | 0.61 | |||||
Price-to-Median-PS-Value | 0.33 | |||||
Earnings Yield (Greenblatt) % | -3.77 | |||||
FCF Yield % | 10.23 | |||||
Forward Rate of Return (Yacktman) % | -45.3 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Changmao Biochemical Engineering Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 649.382 | ||
| EPS (TTM) (HK$) | -0.095 | ||
| Beta | 0.334 | ||
| 3-Year Sharpe Ratio | -1.08 | ||
| 3-Year Sortino Ratio | -1.21 | ||
| Volatility % | 29.6 | ||
| 14-Day RSI | 10.05 | ||
| 14-Day ATR (HK$) | 0.004912 | ||
| 20-Day SMA (HK$) | 0.23515 | ||
| 12-1 Month Momentum % | -21.88 | ||
| 52-Week Range (HK$) | 0.214 - 0.36 | ||
| Shares Outstanding (Mil) | 529.7 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Changmao Biochemical Engineering Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Changmao Biochemical Engineering Co Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Changmao Biochemical Engineering Co Ltd Frequently Asked Questions
What is Changmao Biochemical Engineering Co Ltd(HKSE:00954)'s stock price today?
The current price of HKSE:00954 is HK$0.22. The 52 week high of HKSE:00954 is HK$0.36 and 52 week low is HK$0.21.
When is next earnings date of Changmao Biochemical Engineering Co Ltd(HKSE:00954)?
The next earnings date of Changmao Biochemical Engineering Co Ltd(HKSE:00954) is .
Does Changmao Biochemical Engineering Co Ltd(HKSE:00954) pay dividends? If so, how much?
Changmao Biochemical Engineering Co Ltd(HKSE:00954) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Changmao Biochemical Engineering Co Ltd
No articles.